Boothbay Fund Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10,310
| Closed | -$40K | – | 2365 |
|
|
2022
Q2 | $40K | Buy |
+10,310
| New | +$40K | ﹤0.01% | 1828 |
|
|
2021
Q2 | – | Sell |
-17,858
| Closed | -$165K | – | 1969 |
|
|
2021
Q1 | $165K | Buy |
17,858
+11,744
| +192% | +$109K | 0.01% | 1162 |
|
|
2020
Q4 | $43K | Buy |
+6,114
| New | +$43K | ﹤0.01% | 1031 |
|
|
2020
Q3 | – | Sell |
-1,392
| Closed | -$13K | – | 1156 |
|
|
2020
Q2 | $13K | Hold |
1,392
| – | – | ﹤0.01% | 810 |
|
|
2020
Q1 | $20K | Hold |
1,392
| – | – | ﹤0.01% | 714 |
|
|
2019
Q4 | $16K | Hold |
1,392
| – | – | ﹤0.01% | 720 |
|
|
2019
Q3 | $35K | Hold |
1,392
| – | – | ﹤0.01% | 638 |
|
|
2019
Q2 | $35K | Hold |
1,392
| – | – | ﹤0.01% | 592 |
|
|
2019
Q1 | $59K | Hold |
1,392
| – | – | 0.01% | 589 |
|
|
2018
Q4 | $20K | Sell |
1,392
-43
| -3% | -$618 | ﹤0.01% | 539 |
|
|
2018
Q3 | $100K | Hold |
1,435
| – | – | 0.01% | 587 |
|
|
2018
Q2 | $106K | Hold |
1,435
| – | – | 0.01% | 554 |
|
|
2018
Q1 | $137K | Buy |
1,435
+323
| +29% | +$30.8K | 0.02% | 515 |
|
|
2017
Q4 | $144K | Buy |
1,112
+180
| +19% | +$23.3K | 0.02% | 537 |
|
|
2017
Q3 | $63K | Hold |
932
| – | – | 0.01% | 489 |
|
|
2017
Q2 | $88K | Buy |
932
+365
| +64% | +$34.5K | 0.02% | 534 |
|
|
2017
Q1 | $81K | Hold |
567
| – | – | 0.02% | 593 |
|
|
2016
Q4 | $72 | Buy |
567
+110
| +24% | +$14 | 0.02% | 636 |
|
|
2016
Q3 | $70K | Buy |
+457
| New | +$70K | 0.02% | 578 |
|